Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma

Digestive and Liver Disease

Volumn 48, Issue 8, 2016, Pages 961-969

  Guo, Wei ^a   Dong, Zhiming ^a   Shi, Yabin ^a   Liu, Shengnan ^a   Liang, Jia ^a   Guo, Yanli ^a   Guo, Xin ^a   Shen, Supeng ^a   Shan, Baoen ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal squamous cell carcinoma; Expression; lncRNA; LOC100130476; Methylation

Indexed keywords

LONG UNTRANSLATED RNA LOC100130476; UNCLASSIFIED DRUG; UNTRANSLATED RNA; LONG UNTRANSLATED RNA;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CELL INVASION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CPG ISLAND; ESOPHAGEAL CANCER CELL LINE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXON; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA METHYLATION; TRANSCRIPTION INITIATION SITE; TUMOR SUPPRESSOR GENE; AGED; CHINA; DISEASE COURSE; DNA METHYLATION; DOWN REGULATION; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; UPREGULATION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHINA; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RNA, LONG NONCODING; UP-REGULATION;

EID: 84991000223     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2016.05.010     Document Type: Article

References (36)

1. [1] Jemal, A., Bray, F., Center, M.M., et al. Global cancer statistics. CA: A Cancer Journal for Clinicians 61 (2011), 69–90.
2. [2] Jemal, A., Siegel, R., Xu, J., et al. Cancer statistics, 2010. CA: A Cancer Journal for Clinicians 60 (2010), 277–300.
3. [3] Shahbaz Sarwar, C.M., Luketich, J.D., Landreneau, R.J., et al. Esophageal cancer: an update. International Journal of Surgery 8 (2010), 417–422.
4. [4] Guohong, Z., Min, S., Duenmei, W., et al. Genetic heterogeneity of oesophageal cancer in high-incidence areas of southern and northern China. PLoS ONE, 5, 2010, e9668.
5. [5] Mercer, T.R., Dinger, M.E., Mattick, J.S., Long non-coding RNAs: insights into functions. Nature Reviews Genetics 10 (2009), 155–159.
6. [6] Ponting, C.P., Oliver, P.L., Reik, W., Evolution and functions of long noncoding RNAs. Cell 136 (2009), 629–641.
7. [7] Sun, M., Kraus, W.L., From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease. Endocrine Reviews 36 (2015), 25–64.
8. [8] Zhang, K., Shi, Z.M., Chang, Y.N., et al. The ways of action of long non-coding RNAs in cytoplasm and nucleus. Gene 547 (2014), 1–9.
9. [9] Qiu, M.T., Hu, J.W., Yin, R., et al. Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biology 34 (2013), 613–620.
10. [10] Qi, P., Du, X., The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Modern Pathology 26 (2013), 155–165.
11. [11] Tong, Y.S., Wang, X.W., Zhou, X.L., et al. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Molecular Cancer, 14, 2015, 3.
12. [12] Gao, T., He, B., Pan, Y., et al. Long non-coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression. Molecular Carcinogenesis 54 (2015), 359–367.
13. [13] Wang, C.M., Wu, Q.Q., Li, S.Q., et al. Upregulation of the long non-coding RNA PlncRNA-1 promotes esophageal squamous carcinoma cell proliferation and correlates with advanced clinical stage. Digestive Diseases and Sciences 59 (2014), 591–597.
14. [14] Hu, L., Wu, Y., Tan, D., et al. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. Journal of Experimental and Clinical Cancer Research, 34, 2015, 7.
15. [15] Xu, Y., Wang, J., Qiu, M., et al. Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma. Tumour Biology 36 (2015), 1643–1651.
16. [16] Chen, F.J., Sun, M., Li, S.Q., et al. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Molecular Carcinogenesis 52 (2013), 908–915.
17. [17] Zhang, X., Xu, Y., He, C., et al. Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma. Journal of Surgical Oncology 111 (2015), 834–839.
18. [18] Shi, W.H., Wu, Q.Q., Li, S.Q., et al. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma. Tumour Biology 36 (2015), 2501–2507.
19. [19] Li, J.Y., Ma, X., Zhang, C.B., Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. International Journal of Clinical and Experimental Pathology 7 (2014), 7938–7944.
20. [20] Tong, Y.S., Zhou, X.L., Wang, X.W., et al. Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma. Journal of Translational Medicine, 12, 2014, 233.
21. [21] Pan, F., Yao, J., Chen, Y., et al. A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma. International Journal of Clinical and Experimental Pathology 7 (2014), 2838–2849.
22. [22] Xie, H.W., Wu, Q.Q., Zhu, B., et al. Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis. Tumour Biology 35 (2014), 7743–7754.
23. [23] Morris, K.V., Long antisense non-coding RNAs function to direct epigenetic complexes that regulate transcription in human cells. Epigenetics 4 (2009), 296–301.
24. [24] Li, Q., Su, Z., Xu, X., et al. AS1DHRS4, a head-to-head natural antisense transcript, silences the DHRS4 gene cluster in cis and trans. Proceedings of the National Academy of Sciences of the United States of America 109 (2012), 14110–14115.
25. [25] Esteller, M., Epigenetic gene silencing in cancer: the DNA hypermethylome. Human Molecular Genetics 16 (2007), R50–R59.
26. [26] Gao, T., He, B., Pan, Y., et al. H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway. Clinical and Translational Oncology 16 (2014), 410–417.
27. [27] Zhou, Y., Zhang, X., Klibanski, A., MEG3 noncoding RNA: a tumor suppressor. Journal of Molecular Endocrinology 48 (2012), R45–R53.
28. [28] Zheng, H., Yang, S., Yang, Y., et al. Epigenetically silenced long noncoding-SRHC promotes proliferation of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 141 (2015), 1195–1203.
29. [29] Cao, W., Wu, W., Shi, F., et al. Integrated analysis of long noncoding RNA and coding RNA expression in esophageal squamous cell carcinoma. International Journal of Genomics, 2013, 2013, 480534.
30. [30] Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25 (2001), 402–408.
31. [31] Sasaki, M., Anast, J., Bassett, W., et al. Bisulfite conversion-specific and methylation-specific PCR: a sensitive technique for accurate evaluation of CpG methylation. Biochemical and Biophysical Research Communications 309 (2003), 305–309.
32. [32] Yu, L., Liu, C., Vandeusen, J., et al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nature Genetics 37 (2005), 265–274.
33. [33] Homma, N., Tamura, G., Honda, T., et al. Spreading of methylation within RUNX3 CpG island in gastric cancer. Cancer Science 97 (2006), 51–56.
34. [34] Endoh, M., Tamura, G., Honda, T., et al. RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer. British Journal of Cancer 93 (2005), 1395–1399.
35. [35] Satoh, A., Toyota, M., Itoh, F., et al. DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers. British Journal of Cancer 86 (2002), 1817–1823.
36. [36] Gupta, R.A., Shah, N., Wang, K.C., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464 (2010), 1071–1076.